Literature DB >> 31009735

Reappraisal of probiotics' safety in human.

Farzaneh Sotoudegan1, Marzieh Daniali2, Shokoufeh Hassani2, Shekoufeh Nikfar3, Mohammad Abdollahi4.   

Abstract

Contrary to the safe usage of probiotics for years, their threat is still worthy of attention. Several risks have been explained or mentioned in the case reports, clinical trials and experimental studies. Due to a large number of probiotic products worldwide, the certainty of the safety of such products is a matter of concern. Current review appraises all the available information about a range of adverse effects by probiotics in different populations of consumers and almost all qualified investigations and reports, relevant to the adverse effects of probiotics. Furthermore, the effects of basic or original sources of probiotics were studied. The principally noticed adverse effects of probiotics are systemic infections, gastrointestinal side effects, skin complications, inflammation of endocardium, gene transfer from probiotics to the normal microbial flora, metabolic harmful impacts of probiotics, and immune system stimulation. The most at-risk groups consist of infants, elderly people, patients in hospitalized condition, and those with immunodeficiency due to a genetic or acquired disease. The existing evidence suggests careful evaluation of the risk-benefit ratio of probiotics prior to prescription or recommendation to use.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adverse effects; Probiotics; Risk of toxicity; Safety

Mesh:

Year:  2019        PMID: 31009735     DOI: 10.1016/j.fct.2019.04.032

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  19 in total

1.  Effect of probiotics supplementation on glucose and oxidative stress in type 2 diabetes mellitus: a meta-analysis of randomized trials.

Authors:  Edris Ardeshirlarijani; Ozra Tabatabaei-Malazy; Shahrzad Mohseni; Mostafa Qorbani; Bagher Larijani; Reza Baradar Jalili
Journal:  Daru       Date:  2019-11-05       Impact factor: 3.117

Review 2.  Gut microbiota: a new avenue to reveal pathological mechanisms of constipation.

Authors:  Lei Yang; Yu Wang; Yun Zhang; Wenwen Li; Shu Jiang; Dawei Qian; Jinao Duan
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-03       Impact factor: 5.560

Review 3.  Host microbiota can facilitate pathogen infection.

Authors:  Emily J Stevens; Kieran A Bates; Kayla C King
Journal:  PLoS Pathog       Date:  2021-05-13       Impact factor: 6.823

4.  Histopathological study and intestinal mucous cell responses against Aeromonas hydrophila in Nile tilapia administered with Lactobacillus rhamnosus GG.

Authors:  Suchanit Ngamkala; Khomson Satchasataporn; Chanokchon Setthawongsin; Wuttinun Raksajit
Journal:  Vet World       Date:  2020-05-22

Review 5.  Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential.

Authors:  Zubaidah Hasain; Norfilza Mohd Mokhtar; Nor Azmi Kamaruddin; Nor Azlin Mohamed Ismail; Nurul Huda Razalli; Justin Vijay Gnanou; Raja Affendi Raja Ali
Journal:  Front Cell Infect Microbiol       Date:  2020-05-15       Impact factor: 5.293

6.  Exopolysaccharide Isolated from Lactobacillus plantarum L-14 Has Anti-Inflammatory Effects via the Toll-Like Receptor 4 Pathway in LPS-Induced RAW 264.7 Cells.

Authors:  Mijin Kwon; Jaehoon Lee; Sangkyu Park; Oh-Hee Kwon; Jeongmin Seo; Sangho Roh
Journal:  Int J Mol Sci       Date:  2020-12-05       Impact factor: 5.923

Review 7.  Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.

Authors:  Shan Liu; Jiguo Gao; Mingqin Zhu; Kangding Liu; Hong-Liang Zhang
Journal:  Mol Neurobiol       Date:  2020-08-23       Impact factor: 5.590

8.  Anti-inflammatory effects of Lactobacillus reuteri LM1071 via MAP kinase pathway in IL-1β-induced HT-29 cells.

Authors:  Tae-Rahk Kim; Kyoung-Sook Choi; Yosep Ji; Wilhelm H Holzapfel; Min-Gyu Jeon
Journal:  J Anim Sci Technol       Date:  2020-11-30

9.  Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol.

Authors:  Ping-Guang Lei; Jinqiu Yuan; Man Yang; Yuanyuan Yu
Journal:  BMJ Open       Date:  2019-12-02       Impact factor: 2.692

Review 10.  Perspectives on Probiotics and Bronchopulmonary Dysplasia.

Authors:  Kun Yang; Wenbin Dong
Journal:  Front Pediatr       Date:  2020-10-23       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.